HYP - ETF AI Analysis

Top Page

Golden Eagle Dynamic Hypergrowth ETF (HYP)

Rating:62Neutral

Price Target:―

HYP (Golden Eagle Dynamic Hypergrowth ETF) has a solid overall rating, suggesting it holds a mix of promising growth names alongside some more challenged positions. Strong contributors like Comfort Systems USA, Western Digital, and Viavi Solutions support the fund with robust financial performance, positive earnings calls, and momentum tied to themes like AI and strategic acquisitions, while holdings such as AMN Healthcare, Oscar Health, and Clover Health face financial and operational headwinds that likely weigh on the fund’s rating. The main risk is that many key holdings are tied to high-growth, higher-valuation, and often leveraged businesses, which can make the ETF more sensitive to market volatility and shifts in sentiment toward riskier sectors.

Positive Factors

Strong Year-to-Date Results

The fund has delivered strong gains so far this year, showing that its growth-focused strategy has recently worked well for investors.

Top Holdings with Strong Momentum

Many of the largest positions, such as Dell Technologies, Seagate Tech, and ImmunityBio, have shown strong performance, helping drive the ETF’s overall returns.

Broad Sector Mix within Growth Areas

Exposure across technology, health care, industrials, and several other sectors provides some diversification within a growth-oriented portfolio.

Negative Factors

High Expense Ratio

The fund’s fees are relatively high for an ETF, which means more of the returns are eaten up by costs over time.

Recent Short-Term Weakness

The ETF has experienced a weak recent month, showing that its hypergrowth approach can be volatile over shorter periods.

Heavy U.S. and Technology Focus

With almost all assets in U.S. stocks and a large tilt toward technology, the fund is heavily exposed to swings in the U.S. growth and tech markets.

HYP vs. SPDR S&P 500 ETF (SPY)

AUM68.44M

RegionNorth America

Expense Ratio0.85%

Beta1.70

IssuerGolden Eagle

Inception DateSep 23, 2025

Dividend Yield0.13%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume20,532

30 Day Avg. Volume35,695

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

30.06

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering60

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

HYP Summary

The Golden Eagle Dynamic Hypergrowth ETF (HYP) is an actively managed fund that hunts for fast-growing U.S. companies across the whole stock market, with a strong tilt toward technology and health care. It doesn’t track a set index, but instead follows a “hypergrowth” theme using its own model to pick and adjust holdings. Well-known names in the fund include Dell Technologies and Seagate Technology. Someone might invest in HYP for the chance at higher long-term growth from innovative companies, but it is heavily focused on growth and tech-related stocks, so its price can swing a lot and may drop sharply in market downturns.

How much will it cost me?The Golden Eagle Dynamic Hypergrowth ETF (HYP) has an expense ratio of 0.85%, which means you’ll pay $8.50 per year for every $1,000 invested. This is higher than average because it’s actively managed, requiring more research and adjustments to target high-growth companies.

What would affect this ETF?The Golden Eagle Dynamic Hypergrowth ETF (HYP) could benefit from strong growth in the U.S. technology and healthcare sectors, as well as increased demand for innovative companies reshaping industries. However, rising interest rates or economic slowdowns may negatively impact high-growth companies, particularly those in cyclical sectors like consumer discretionary and financials. Regulatory changes or geopolitical tensions could also pose risks to the fund's holdings.

HYP Top 10 Holdings

HYP is leaning hard into U.S. hypergrowth, with a clear tilt toward tech and health care names that are either sprinting ahead or stumbling. Dell Technologies and Silicon Motion are two of the fund’s key engines right now, riding strong AI and chip demand, while Bloom Energy adds a fast-rising clean-tech flavor despite some financial baggage. On the health side, Oscar Health and Clover Health have been climbing but still feel fragile, and ImmunityBio is lagging, acting like a brake on performance. Overall, it’s a concentrated bet on volatile, high-octane innovators.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
LPG	Dorian LPG	2.56%	$1.75M	$2.03B	59.35%	66 Neutral
CDNA	CareDx	2.54%	$1.74M	$2.26B	279.76%	77 Outperform
PBF	PBF Energy	2.54%	$1.74M	$8.57B	233.39%	55 Neutral
DINO	HF Sinclair Corporation	2.54%	$1.74M	$16.26B	115.93%	68 Neutral
HPE	Hewlett Packard Enterprise	2.54%	$1.73M	$63.43B	150.95%	68 Neutral
VIAV	Viavi Solutions	2.54%	$1.73M	$9.12B	278.59%	71 Outperform
INSW	International Seaways	2.52%	$1.73M	$4.76B	128.70%	72 Outperform
DELL	Dell Technologies	2.52%	$1.73M	$262.79B	229.43%	65 Neutral
PENG	Penguin Solutions	2.52%	$1.72M	$2.70B	121.94%	61 Neutral
AXTI	AXT	2.51%	$1.72M	$3.95B	3154.50%	61 Neutral

HYP Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

28.80

Negative

100DMA

27.83

Negative

200DMA

26.48

Negative

Market Momentum

MACD

-1.18

Positive

RSI

44.49

Neutral

STOCH

46.24

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For HYP, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 26.78, equal to the 50-day MA of 28.80, and equal to the 200-day MA of 26.48, indicating a bearish trend. The MACD of -1.18 indicates Positive momentum. The RSI at 44.49 is Neutral, neither overbought nor oversold. The STOCH value of 46.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HYP.

HYP Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
HYP	―	―	$68.44M	0.85%	62 Neutral
AOTG	―	―	$96.94M	0.75%	74 Outperform
JGRW	―	―	$86.46M	0.57%	74 Outperform
TSEL	―	―	$77.69M	0.67%	71 Outperform
SEMG	―	―	$61.95M	0.60%	72 Outperform
RILA	―	―	$41.67M	0.50%	73 Outperform

Performance Comparison

HYP

Golden Eagle Dynamic Hypergrowth ETF

25.76

1.62

6.71%

AOTG

AOT Growth and Innovation ETF

―

JGRW

Jensen Quality Growth ETF

―

TSEL

Touchstone Sands Capital US Select Growth ETF

―

SEMG

Suncoast Select Growth ETF

―

RILA

Indexperts Gorilla Aggressive Growth ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents